Dr. Abdennadher received an MD from the Medical School of Tunis in Tunisia in 2008 and completed neurosurgery residency in Tunisia and France in 2010. Then she moved to Boston, Massachusetts and worked on a study about cardiorespiratory changes in patients at higher risk for sudden unexpected death in epilepsy (SUDEP), at Brigham and Women’s Hospital, Harvard University in 2011. Following her passion for treating epilepsy and improving health in patients with drug-resistant epilepsy (uncontrolled seizures), she completed a neurology residency at the University of Texas at Dell Medical School in Austin in 2017, then fellowships in Epilepsy and Clinical Neurophysiology at the National Institute of Neurological disorders and Stroke, National Institutes of Health in 2019. She became an Assistant Professor of Neurology at Boston University Medical Center in 2019.

Dr. Abdennadher is a board certified neurologist and clinical neurophysiologist, expert in treating patients with epilepsy, with a focus on drug-resistant epilepsy and uncontrolled seizures, neuroimaging of epilepsy, seizure focus localization and epilepsy surgery. Her research focuses on neurophysiologic and brain imaging methods to localize seizure focus in drug-resistant focal epilepsy and to improve biomarkers of epileptogenicity. She was the recipient of the Grinspoon Award for a study about perfusion MRI to localize seizure foci during presurgical evaluation (2020), the BU CTSI Translational Research Award for a study about blood-brain barrier exchanges in epilepsy using (noncontrast) arterial-spin labeling (ASL) MRI (2022), and the BU ADRC pilot grant to investigate epilepsy contribution to Alzheimer's disease progression (2024).